Literature DB >> 15199271

Complications of osmotic dilators.

E Steve Lichtenberg1.   

Abstract

This article reviews safety, efficacy, and complications of intracervical osmotic devices and discusses diagnostic, therapeutic, and preventative measures for managing them. Osmotic dilators have been used to ripen the cervix in gynecologic and obstetric procedures for centuries. Their gradual effect in softening and dilating the cervix reduces the chance of stretch injury or perforation and could enhance completeness of evacuation of the uterine cavity. Natural and synthetic devices are available, each with unique properties. Notwithstanding major advances in prostaglandin analogs as cervical ripeners, these mechanical devices continue to play a vital role in cervical preparation. In the event of an unfavorable cervix, they are adjuncts for accelerating inductions of labor and for safe uterine entry during hysteroscopy and diagnostic dilation and curettage. For inducing pregnancy, they are routinely used as cervical ripeners from the late first trimester onward. The English-language literature was surveyed. The author used citations from a MEDLINE search, 2 unpublished case reports, and personal experience. Laminaria and Dilapan dilators can get trapped and fragment with the potential for serious adverse clinical and legal consequences. Lamicel devices do not share this feature. Serious infection is uncommon and anaphylaxis is rare. Timely, well-selected imaging techniques can aid diagnosis. Preventative measures could reduce the number and severity of osmotic dilator-associated complications. Measures suggested by some include predilating with metal dilators, incorporating laminaria or Lamicel devices with Dilapan, adding misoprostol, and using sonohysterography. However, these measures, singly and in combination, are unlikely to eliminate all complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199271     DOI: 10.1097/00006254-200407000-00022

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  5 in total

1.  A prospective pilot study of Dilapan-S compared with Propess for induction of labour at 41+ weeks in nulliparous pregnancy.

Authors:  David A Crosby; Claire O'Reilly; Helen McHale; Fionnuala M McAuliffe; Rhona Mahony
Journal:  Ir J Med Sci       Date:  2017-12-21       Impact factor: 1.568

2.  Leukocytosis during cervical preparation with osmotic dilators for dilation and evacuation.

Authors:  Lyndsey S Benson; Jordan Stevens; Elizabeth A Micks; Sarah W Prager
Journal:  SAGE Open Med       Date:  2021-01-12

3.  A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial.

Authors:  K S Oppegaard; M Lieng; A Berg; O Istre; E Qvigstad; B-I Nesheim
Journal:  BJOG       Date:  2010-01       Impact factor: 6.531

4.  Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design.

Authors:  K S Oppegaard; B-I Nesheim; O Istre; E Qvigstad
Journal:  BJOG       Date:  2008-01-16       Impact factor: 6.531

5.  Does self-administered vaginal misoprostol result in cervical ripening in postmenopausal women after 14 days of pre-treatment with estradiol? Trial protocol for a randomised, placebo-controlled sequential trial.

Authors:  K S Oppegaard; M Lieng; A Berg; O Istre; E Qvigstad; B-I Nesheim
Journal:  BJOG       Date:  2008-06       Impact factor: 6.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.